AgeX Therapeutics Buy Hold or Sell Recommendation
| AGEDelisted Stock | USD 0.74 0.01 1.37% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding AgeX Therapeutics is 'Not Rated'. Macroaxis provides AgeX Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AGE positions.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. Note, we conduct extensive research on individual companies such as AgeX and provide practical buy, sell, or hold advice based on investors' constraints. AgeX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
AgeX |
Execute AgeX Therapeutics Buy or Sell Advice
The AgeX recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on AgeX Therapeutics. Macroaxis does not own or have any residual interests in AgeX Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute AgeX Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
AgeX Therapeutics Trading Alerts and Improvement Suggestions
| AgeX Therapeutics is now traded under the symbol SER. Please update your portfolios or report it if you believe this is an error. Report It! | |
| AgeX Therapeutics is not yet fully synchronised with the market data | |
| AgeX Therapeutics has some characteristics of a very speculative penny stock | |
| AgeX Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| AgeX Therapeutics has 4.37 M in debt with debt to equity (D/E) ratio of 0.75, which is OK given its current industry classification. AgeX Therapeutics has a current ratio of 0.19, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for AgeX to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 142 K. Reported Net Loss for the year was (14.8 M) with profit before taxes, overhead, and interest of 125 K. | |
| AgeX Therapeutics has about 645 K in cash with (7.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 76.0% of AgeX Therapeutics shares are held by company insiders |
AgeX Therapeutics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. AgeX analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. AgeX analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
AgeX Therapeutics Returns Distribution Density
The distribution of AgeX Therapeutics' historical returns is an attempt to chart the uncertainty of AgeX Therapeutics' future price movements. The chart of the probability distribution of AgeX Therapeutics daily returns describes the distribution of returns around its average expected value. We use AgeX Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of AgeX Therapeutics returns is essential to provide solid investment advice for AgeX Therapeutics.
| Mean Return | 0.55 | Value At Risk | -9.2 | Potential Upside | 8.20 | Standard Deviation | 6.59 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of AgeX Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Michael West of 3125 shares of AgeX Therapeutics subject to Rule 16b-3 [view details]
AgeX Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as AgeX . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About AgeX Therapeutics Buy or Sell Advice
When is the right time to buy or sell AgeX Therapeutics? Buying financial instruments such as AgeX Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having AgeX Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Adviser Favorites Thematic Idea Now
Adviser Favorites
Financial advisors frequently recommend that individuals diversify their investment portfolios with a mix of different types of stocks. These can include blue-chip stocks, growth stocks, and dividend stocks. The Adviser Favorites theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Adviser Favorites Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in AgeX Stock
If you are still planning to invest in AgeX Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AgeX Therapeutics' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |